BASF to sell Illinois site
BASF has agreed to sell its manufacturing site in Kankakee, Illinois and the associated businesses of vegetable-oil-based raw material sterols and natural vitamin E, anionic surfactants and esters to private equity firm One Rock Capital Partners. Terms are not being disclosed. Subject to regulatory approval, this should be completed in 1H 2021.
The site, which is operated by the Nutrition & Health and the Care Chemicals divisions, came with the acquisition of Cognis in 2010 and it now employs about 160. BASF regarded Kanakee as no longer a strategic fit. The company continues to produce anionic surfactants for the home care, personal care and industrial formulation sectors at other sites.
RELATED ARTICLES
Travertine Technologies and precious metal refiner Sabin Metal have announced plans have revealed plans to build a demonstration plant at Sabin’s main facility near Rochester, New York.
Two CDMOs have separately announced expansions in their antibody-drug conjugate (ADC) manufacturing capabilities and capacity on opposite sides of the Atlantic.
OCSiAl has opened its first European graphene nanotubes facility in Serbia. It will produce 60 tonnes/year under the Tuball band and the company plans to double this by launching a second synthesis unit within the next year. The modular design means it is able to scale production rapidly.
A pilot enforcement project carried out by national enforcement authorities in 13 European Economic Area (EEA) countries between November 2023 and April 2024 found that 6% of about 4,500 cosmetic products inspected contained hazardous substances.
Biosynth, which supplies critical raw materials and services for diagnostics, vaccines and pharmaceuticals, has officially opened its Biosynth Biological Technology site at Lifebay, a technology park in Suzhou, China.
Spanish energy and chemicals company Cepsa has renamed itself Moeve.
